. .

 
Zuruecksetzen

Suchergebnis - LONZA GROUP AG NAMENS-AKTIEN SF 1

Zeit Titel
08.10 10:01dpa-AFX: *PREVAIL THERAPEUTICS AND LONZA ESTABLISH STRATEGIC COLLABORATION TO DEVELOP PREVAIL'S NOVEL AAV9 GENE THERAPY PROGRAMS
31.07 14:34dpa-AFX: *OMEROS AND LONZA ENTER LONG-TERM MANUFACTURING AGREEMENT FOR COMMERCIAL SUPPLY OF NARSOPLIMAB
24.07 06:58dpa-AFX: Lonza H1 Net Profit Down, Sales Rise; Confirms FY19, Mid-Term View
24.07 06:42dpa-AFX: *LONZA SEES TO ACHIEVE A NET DEBT / CORE EBITDA LEVEL OF BELOW 2X AT THE END OF 2019
24.07 06:42dpa-AFX: *LONZA SEES 2019 CAPEX TO REACH 11-13% OF SALES
24.07 06:41dpa-AFX: *LONZA CONFIRMS 2019 OUTLOOK OF MID-TO-HIGH SINGLE-DIGIT SALES GROWTH AND A SUSTAINED CORE EBITDA MARGIN
24.07 06:41dpa-AFX: *LONZA H1 CORE EBITDA UP 7/7% TO CHF 828 MLN; CORE EBITDA MARGIN OF 27.8%
24.07 06:40dpa-AFX: *LONZA H1 CORE PROFIT CHF 520 MLN; CORE EBIT CHF 643 MLN LAST YEAR
24.07 06:39dpa-AFX: *LONZA H1 SALES CHF 2.976 BLN VS CHF 2.796 BLN LAST YEAR
24.07 06:38dpa-AFX: *LONZA H1 CORE EPS CHF 6.96 VS CHF 6.32 LAST YEAR
23.04 10:12dpa-AFX: *LONZA +4% AN SMI-SPITZE - POSITIVE ANALYSTENSTUDIEN NACH ZAHLEN
18.04 08:03dpa-AFX: Lonza Maintains 2019 Outlook
18.04 08:03dpa-AFX: Lonza Maintains 2019 Outlook
18.04 06:57dpa-AFX: *LONZA SAYS ALL INVESTMENTS IN HEALTHCARE BUSINESSES PROGRESSING AS PLANNED TO FURTHER ACCELERATE GROWTH
18.04 06:57dpa-AFX: *LONZA SAYS SPECIALTY INGREDIENTS CONTINUED TO FACE HEADWINDS IN Q1
18.04 06:57dpa-AFX: *LONZA MAINTAINS FY OUTLOOK 2019 AND ACCELERATES PORTFOLIO REVIEW ONGOING
30.01 10:21dpa-AFX: *LONZA -5,6% NACH JAHRESZAHLEN UND RÜCKTRITT VON KONZERNCHEF RIDINGER
30.01 07:17dpa-AFX: Lonza FY18 Profit Drops; Confirms 2022 View; Names Marc Funk CEO
30.01 07:17dpa-AFX: Lonza FY18 Profit Drops; Confirms 2022 View; Names Marc Funk CEO
30.01 06:55dpa-AFX: *LONZA EXPECTS MID-TO-HIGH-SINGLE DIGIT SALES GROWTH FOR 2019, SUSTAINED HIGH CORE EBITDA MARGIN LEVEL

© 2000-2019 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen |
2019 vwd Vereinigte Wirtschaftsdienste GmbH